Abstract
Fiberoptic phototherapy is used widely throughout the USA but data comparing the efficacy of commercially available fiberoptic phototherapy systems are sparse. We conducted a randomized controlled trial to compare the efficacy of the Ohmeda Biliblanket and the Fiberoptic Medical Wallaby neonatal pad in the treatment of jaundice in infants <2500g. The decision to use phototherapy was based on standard clinical guidelines currently in use in our NICU. 28 infants were treated with the Wallaby neonatal system and 23 with the Ohmeda. The illuminated surface area of the Wallaby pad is 125cm2 and the Ohmeda pad 133.25cm2. Mean spectral irradiance in the 425-475nm range, measured over the course of the study was 18.2μw/cm2 /nm for the Wallaby and 19.9μw/cm2 /nm for the Ohmeda, and the spectral power (irradiance x surface area) was 2.28mW/nm and 2.65mW/nm respectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
